| Q89890427 | A new paradigm for personalized prophylaxis for patients with severe haemophilia A |
| Q37097019 | Coagulation factor XII genetic variation, ex vivo thrombin generation, and stroke risk in the elderly: results from the Cardiovascular Health Study. |
| Q88628403 | Continuous thrombin generation in whole blood: New applications for assessing activators and inhibitors of coagulation |
| Q36956166 | Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass |
| Q33679124 | Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay |
| Q43092928 | Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor-induced hypercoagulability in vitro and in vivo |
| Q50324804 | Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram. |
| Q92928182 | Elevated activated partial thromboplastin time-based clot waveform analysis markers have strong positive association with acute venous thromboembolism |
| Q35897688 | Genetic Determinants of Thrombin Generation and Their Relation to Venous Thrombosis: Results from the GAIT-2 Project |
| Q38233155 | Global assays of hemostasis |
| Q35025682 | Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk |
| Q45856680 | Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors |
| Q34749623 | Influence of blood lipids on global coagulation test results |
| Q92505974 | Mode of Delivery Does Not Influence Postpartum Hypercoagulability Measured by Thrombin Generation or Thromboelastometry |
| Q88514713 | Protein disulfide isomerase enhances tissue factor-dependent thrombin generation |
| Q89081057 | Prothrombin conversion is accelerated in the antiphospholipid syndrome and insensitive to thrombomodulin |
| Q35433005 | The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera |
| Q45880852 | Thrombin generation and other coagulation parameters in a patient with homozygous congenital protein S deficiency on treatment with rivaroxaban |
| Q55382925 | Thrombin generation in low plasma volumes. |
| Q48185830 | Thrombin generation test as a marker for high risk venous thrombosis pregnancies. |
| Q93092051 | Visceral Adiposity Is an Independent Determinant of Hypercoagulability as Measured by Thrombin Generation in Morbid Obesity |